Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia

ClinicalTrials.gov ID: NCT00099528

Public ClinicalTrials.gov record NCT00099528. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

REN-1654 in Post-Herpetic Neuralgia: a Multi-Center, Placebo Controlled, 3-week Dose-Finding Study, With a 3-Week Active-Treatment Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to gain initial safety and efficacy data on the experimental agent REN-1654 in patients with painful post-herpetic neuralgia (PHN).

Study identification

NCT ID
NCT00099528
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Renovis
Industry
Enrollment
90 participants

Conditions and interventions

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2003 (Type not available)
Primary completion
Not listed
Completion
Dec 2004 (Type not available)
Last update posted
Jul 29, 2010

2003 – 2004

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
North Alabama Neuroscience Research Associates Huntsville Alabama 35801 —
Pivotal Research Centers Peoria Arizona 85381 —
HOPE Research Institute Phoenix Arizona 85032 —
Advanced Clinical Therapeutics, LLC Tuscon Arizona 85712 —
UCSD Center for Pain and Palliative Medicine La Jolla California 92037 —
Neurophysiologic Laboratory Laguna Hills California 92653 —
Colorado Neurology and Headache Center Denver Colorado 80218 —
Palm Beach Neurological Center Palm Beach Gardens Florida 33401 —
Suncoast Neuroscience Associates, Inc. St. Petersburg Florida 33701 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
University of Michigan Health Center, Dept. Anesthesiology Ann Arbor Michigan 48109 —
Washington University School of Medicine St Louis Missouri 63110 —
A and A Pain Institute St Louis Missouri 63141 —
The Center for Clinical Research Winston-Salem North Carolina 27103 —
Diagnostic Center of Houston Houston Texas 77004 —
University of Wisconsin at Madison Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00099528, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2010 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00099528 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →